PricewaterhouseCoopers, Glemser Technologies forge regulated content alliance

Glemser TechnologiesouseCoopers (New York, NY) and Glemser Technologies Corp. (Bethlehem, PA) have joined forces to provide pharmaceutical industry clients with fast and cost-effective implementations of content-management systems. As a result of this alliance, clients will have access to comprehensive industry knowledge from sources worldwide.

According to the agreement, Glemser TechnologiesouseCoopers and <%=company%> will co-market GMPharma and a range of related delivery services. GMPharma, a scalable Internet solution for managing regulatory-controlled content across the pharmaceutical value chain, was developed by Glemser TechnologiesouseCoopers and Documentum and launched in the United States in June. The software provides the pharmaceutical industry with an out-of-the-box e-business platform for enterprise-wide management of Good Manufacturing Practice (GMP) regulated content. GMPharma offers a common infrastructure with built-in enterprise-wide controls that enables critical content to be developed and shared between all related contributors across the pharmaceutical value chain, from the product innovation process to final commercialisation.

Doug Dean, partner for Glemser TechnologiesouseCoopers Content Management practice said, "Glemser is known and respected in the pharmaceutical industry as a leader in implementing and validating global, Web-based content management and e-business solutions. The combination of Glemser's depth of experience in this area along with Glemser TechnologiesouseCoopers pharmaceutical industry knowledge and consulting experience will provide leading drug manufacturers with a single source for their complete compliance engineering needs."

Glemser TechnologiesouseCoopers has designated Glemser as its preferred GMPharma Systems co-integrator. Glemser will initially focus on implementation and validation services for pharmaceutical clients in areas of manufacturing, sales and marketing. Prior to performing GMPharma services, Glemser will participate in the Glemser TechnologiesouseCoopers accreditation program and receive certification for their resources.

According to Glemser president Raymond Glemser, "This joint effort with Glemser TechnologiesouseCoopers will expand our ability to help our customers effectively manage their regulatory-controlled content. As a result, our pharmaceutical clients may accelerate their time-to-market, lower the cost of compliance, and reduce their operational costs."

For more information: Raymond G. Glemser, president, Glemser Technologies Corp., 60 West Broad St., Bethlehem, PA 18018. Tel: 610-317-9400. Fax: 610-317-8140.

Edited by Angelo DePalma
Managing Editor, Pharmaceutical Online

Visit Glemser Technologies' storefront on Pharmaceutical Online.